Infinium Pharmachem Limited (NSE:INFINIUM)
287.90
-15.15 (-5.00%)
At close: May 30, 2025
Infinium Pharmachem Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 |
Cash & Equivalents | 157.52 | 119.11 | 59.79 | 54.51 | 12.37 | 1.36 | Upgrade
|
Cash & Short-Term Investments | 157.52 | 119.11 | 59.79 | 54.51 | 12.37 | 1.36 | Upgrade
|
Cash Growth | 23.40% | 99.20% | 9.69% | 340.65% | 810.30% | 14.87% | Upgrade
|
Accounts Receivable | 252.23 | 204.53 | 154.32 | 153.92 | 104.27 | 74.06 | Upgrade
|
Other Receivables | - | 20.96 | 31.58 | 31.2 | 10 | 15.31 | Upgrade
|
Receivables | 313.15 | 225.48 | 185.9 | 185.11 | 114.4 | 89.77 | Upgrade
|
Inventory | 225.97 | 270.08 | 231.03 | 179.11 | 86.68 | 67.27 | Upgrade
|
Other Current Assets | - | 35.43 | 36.41 | 18.1 | 9.65 | 2.11 | Upgrade
|
Total Current Assets | 696.64 | 650.11 | 513.13 | 436.84 | 223.1 | 160.51 | Upgrade
|
Property, Plant & Equipment | 340.83 | 196.5 | 188.06 | 126.79 | 81.09 | 41.55 | Upgrade
|
Long-Term Investments | 290.25 | - | - | - | 2.65 | 2.65 | Upgrade
|
Long-Term Deferred Tax Assets | 0.88 | 0.17 | 0.52 | 0.67 | 0.57 | 0.49 | Upgrade
|
Other Long-Term Assets | 9.96 | 7.74 | 4.41 | 25.69 | 0.69 | 0.64 | Upgrade
|
Total Assets | 1,339 | 854.53 | 706.12 | 590 | 308.09 | 205.84 | Upgrade
|
Accounts Payable | 110.18 | 45.13 | 68.28 | 118.17 | 113.87 | 60.03 | Upgrade
|
Accrued Expenses | - | 5.41 | 4.12 | 12.6 | 5.3 | 5.67 | Upgrade
|
Short-Term Debt | - | 33.53 | 155.63 | 86.71 | 47.17 | 32.02 | Upgrade
|
Current Portion of Long-Term Debt | 130.44 | 0.85 | 36.16 | 2.26 | 0.02 | - | Upgrade
|
Current Income Taxes Payable | 14.45 | 36.71 | 30.91 | 19.39 | 10.49 | 3.72 | Upgrade
|
Other Current Liabilities | 45.02 | 52.5 | 72.6 | 75.41 | 2.85 | 4.62 | Upgrade
|
Total Current Liabilities | 300.09 | 174.13 | 367.69 | 314.54 | 179.7 | 106.06 | Upgrade
|
Long-Term Debt | 58.65 | 78.06 | 100.61 | 136.24 | 57.93 | 56.62 | Upgrade
|
Total Liabilities | 549.29 | 252.2 | 468.3 | 450.78 | 237.63 | 162.68 | Upgrade
|
Common Stock | 139.16 | 139.16 | 50.83 | 10.17 | 10.17 | 10.17 | Upgrade
|
Additional Paid-In Capital | - | 161.28 | - | 7.66 | 7.66 | 7.66 | Upgrade
|
Retained Earnings | - | 287.88 | 174.85 | 112.96 | 52.64 | 25.34 | Upgrade
|
Comprehensive Income & Other | 492.69 | -0.52 | -0.07 | 0.24 | - | - | Upgrade
|
Total Common Equity | 631.85 | 587.79 | 225.61 | 131.02 | 70.46 | 43.16 | Upgrade
|
Minority Interest | 157.41 | 14.54 | 12.21 | 8.19 | - | - | Upgrade
|
Shareholders' Equity | 789.26 | 602.33 | 237.82 | 139.22 | 70.46 | 43.16 | Upgrade
|
Total Liabilities & Equity | 1,339 | 854.53 | 706.12 | 590 | 308.09 | 205.84 | Upgrade
|
Total Debt | 189.09 | 112.44 | 292.4 | 225.21 | 105.12 | 88.64 | Upgrade
|
Net Cash (Debt) | -31.57 | 6.67 | -232.6 | -170.69 | -92.75 | -87.28 | Upgrade
|
Net Cash Per Share | -2.27 | 0.48 | -22.88 | -16.79 | -9.12 | -8.59 | Upgrade
|
Filing Date Shares Outstanding | 13.9 | 13.92 | 13.92 | 10.17 | 10.17 | 10.17 | Upgrade
|
Total Common Shares Outstanding | 13.9 | 13.92 | 10.17 | 10.17 | 10.17 | 10.17 | Upgrade
|
Working Capital | 396.54 | 475.98 | 145.44 | 122.3 | 43.4 | 54.45 | Upgrade
|
Book Value Per Share | 45.46 | 42.24 | 22.19 | 12.89 | 6.93 | 4.25 | Upgrade
|
Tangible Book Value | 631.85 | 587.79 | 225.61 | 131.02 | 70.46 | 43.16 | Upgrade
|
Tangible Book Value Per Share | 45.46 | 42.24 | 22.19 | 12.89 | 6.93 | 4.25 | Upgrade
|
Land | - | 7.98 | 7.98 | 7.98 | 7.98 | 5.48 | Upgrade
|
Buildings | - | 65.52 | 51.3 | 12.84 | 12.84 | 12.84 | Upgrade
|
Machinery | - | 167.51 | 149.32 | 56.52 | 55.76 | 50.98 | Upgrade
|
Construction In Progress | - | 0.15 | - | 84.8 | 38.6 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.